Dementia diagnosis in developing countries: a cross-cultural validation study.

By M. Prince, D. Acosta, H. Chiu, M. Scazufca, M. Varghese. The Lancet, 2003

596 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 (2022, unknown): “28,29 We also adjusted for bias in US medical claims data but, because there was evidence of differential bias by age, we used a separate model with a spline on age to appropriately make this adjustment (appendix p 14).”
Recent global trends in the prevalence and incidence of dementia, and survival with dementia (2016, methodology): “This may also be countered through the application of structured assessments and diagnostic algorithms, such as the AGECAT computerised algorithm linked to the Geriatric Mental State [57], as employed in the MRC CFAS studies [27], or the 10/66 Dementia Research Group’s cross-culturally validated dia”
The global prevalence of dementia: A systematic review and metaanalysis (2013, background): “In the 10/66 dementia Research Group studies, the group’s 10/66 dementia diagnosis (developed, calibrated, and validated in a 26-site pilot study [40]) was both more prevalent than that according to DSM-IV criteria, and more consistent between sites; the prevalence of DSM-IV dementia was particularl”